 | Up a level |
Koehler, P., Stecher, M., Cornely, O. A., Koehler, D., Vehreschild, M. J. G. T., Bohlius, J., Wisplinghoff, H. and Vehreschild, J. J. (2019). Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis. Clin. Microbiol. Infect., 25 (10). S. 1200 - 1213. OXFORD: ELSEVIER SCI LTD. ISSN 1469-0691
Kuhr, K., Scheckel, B., Haque, M., Weigl, A., Monsef, I, Bohlius, J. and Skoetz, N. (2018). Intravenous versus oral versus no iron with or without erythropoiesisstimulating agents (ESA) for anaemic cancer patients: A systematic review and network meta-analysis. Oncol. Res. Treat., 41. S. 215 - 217. BASEL: KARGER. ISSN 2296-5262
Vehreschild, J. J., Boehme, A., Cornely, O. A., Kahl, C., Karthaus, M., Kreuzer, K. -A., Maschmeyer, G., Mousset, S., Ossendorf, V., Penack, O., Vehreschild, M. J. G. T. and Bohlius, J. (2014). Prophylaxis of infectious complications with colony-stimulating factors in adult cancer patients undergoing chemotherapy-evidence-based guidelines from the Infectious Diseases Working Party AGIHO of the German Society for Haematology and Medical Oncology (DGHO). Ann. Oncol., 25 (9). S. 1709 - 1720. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041
Weigl, A., Koehler, N., Monsef, I., Bohlius, J., Becker, I., Kuhr, K. and Skoetz, N. (2017). INTRAVENOUS IRON VERSUS ORAL IRON VERSUS NO IRON WITH OR WITHOUT ERYTHROPOIESISSTIMULATING AGENTS FOR CANCER PATIENTS WITH ANAEMIA: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS. Haematologica, 102. S. 334 - 335. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078